Skip to main content
Earnings Labs
Inhibrx Biosciences Inc. logo

Inhibrx Biosciences Inc. (INBX) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$97.22

+9.72%

Mkt Cap $1.37B

EPS — Estimate vs Actual

Quarterly History

Q1 2026

Mar 19, 2026

$1.11M——-$2.08-$2.11-1.44%
Q4 2025

Nov 14, 2025

———-$2.08-$2.28-9.62%
Q3 2025

Aug 13, 2025

—$1.30M—-$2.92-$1.85+36.64%
Q2 2025

May 14, 2025

———-$2.55-$2.80-9.80%
Q1 2025

Mar 17, 2025

—$100.00K—-$2.88-$3.09-7.29%
Q4 2024

Nov 14, 2024

———-$3.06-$2.84+7.19%
Q3 2024

Aug 13, 2024

—$100.00K—-$3.60$125.48+3585.56%
Q2 2024

Jun 3, 2024

$50.00K——-$1.04-$1.44-38.46%
Q1 2024

Feb 28, 2024

$50.00K$1.63M+3168.00%-$1.07-$1.73-61.68%
Q4 2023

Nov 9, 2023

$50.00K$119.00K+138.00%-$1.01-$1.10-8.91%
Q3 2023

Aug 7, 2023

—$30.00K—-$1.02-$1.08-5.88%
Q2 2023

May 8, 2023

$150.00K$17.00K-88.67%-$0.84-$1.12-33.33%
Q1 2023

Mar 6, 2023

$994.00K$274.00K-72.43%-$0.80-$0.95-18.75%
Q4 2022

Nov 7, 2022

$633.33K$278.00K-56.11%-$1.01-$0.90+10.89%
Q3 2022

Aug 8, 2022

$1.07M$711.00K-33.50%-$0.84-$0.97-15.48%
Q2 2022

May 9, 2022

$1.10M$915.00K-17.01%-$0.62-$0.80-29.03%
Q1 2022

Feb 28, 2022

$1.21M$2.84M+134.70%-$0.53-$0.55-3.77%
Q4 2021

Nov 9, 2021

$1.50M$2.51M+67.20%-$0.57-$0.54+5.26%
Q3 2021

Aug 9, 2021

$820.00K$918.00K+11.95%-$0.51-$0.55-7.84%
Q2 2021

May 13, 2021

$1.01M$863.00K-14.52%-$0.61-$0.51+16.39%
Q1 2021

Mar 12, 2021

—$2.78M—-$0.50-$0.47+6.00%
Q4 2020

Nov 13, 2020

—$5.83M—-$0.60-$0.77-28.33%
Q3 2020

Aug 19, 2020

—$872.00K——-$0.70—
Q2 2020

Jun 30, 2020

—$3.33M——-$0.50—
Q4 2019

Dec 31, 2019

—$267.00K——-$0.57—
Q3 2019

Sep 30, 2019

—$794.00K——-$0.70—
Q2 2019

Jun 30, 2019

—$1.00M——-$0.39—
Q1 2019

Mar 31, 2019

—$7.03M——-$0.13—
Q4 2018

Dec 31, 2018

—$2.27M——-$0.24—
Q2 2018

Jun 30, 2018

—$2.50M——-$0.25—
Q1 2018

Mar 31, 2018

—$2.50M——-$0.32—
Q4 2017

Dec 31, 2017

—$281.00K——-$0.44—